This trial is completed!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Facial Acne Vulgaris
and you are
between 16 and 45
years old
-
The phase for this study is not defined.
Show me locations

The purpose

This study is proposed to evaluate Sebacia Microparticle treatment in patients with facial inflammatory acne vulgaris.

Provided treatments

  • Device: Sebacia Microparticles
Tris trial is registered with FDA with number: NCT02758041. The sponsor of the trial is Sebacia, Inc. and it is looking for 85 volunteers for the current phase.
Official trial title:
A Study to Evaluate Sebacia Microparticles in Patients With Inflammatory Acne Vulgaris